Mycotoxin risk assessment for the purpose of setting international regulatory standards
- PMID: 15352440
- DOI: 10.1021/es035353n
Mycotoxin risk assessment for the purpose of setting international regulatory standards
Abstract
The 2003 Council for Agricultural Science and Technology Mycotoxin report states that one 21st century goal is the development of uniform regulations worldwide for foodborne mycotoxin contamination. This study informs that endeavor by a risk assessment and economic analysis of two important mycotoxins: fumonisins and aflatoxins. The goals are to identify the nations that would be most heavily impacted by tighter mycotoxin regulations, examine costs and benefits as a function of regulatory stringency, and address risk-risk tradeoffs between health benefits and economic losses from compliance with those regulations. Among industrial nations, the United States would experience the heaviest economic losses from more precautionary mycotoxin standards. Environmental conditions in the developing world, however, are more conducive to mycotoxin accumulation in crops. Contrary to concerns expressed among policymakers, the less developed countries that would likely experience the greatest loss from tighter mycotoxin standards are not sub-Saharan African nations, but China and Argentina. If a fumonisin standard of 0.5 mg/kg were adopted worldwide, total export losses from fumonisins in corn may exceed 300 million dollars annually: 3-fold higher than if the less stringent U.S. standard of 2 mg/kg were adopted. Likewise, export losses from aflatoxins in peanuts may exceed 450 million dollars under the current EU regulatory standard of 4 microg/kg: almost 5-fold higher than if the U.S. standard of 20 microg/kg were adopted. Stricter standards are unlikely to improve health significantly. In developing nations such as China where hepatitis B and C are prevalent, tighter aflatoxin standards may increase health risks until improved control methods for aflatoxins are found, as high-quality crops may be exported instead of being consumed domestically.
Similar articles
-
Aflatoxin regulations in a network of global maize trade.PLoS One. 2012;7(9):e45151. doi: 10.1371/journal.pone.0045151. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049773 Free PMC article.
-
Mycotoxin reduction in Bt corn: potential economic, health, and regulatory impacts.Transgenic Res. 2006 Jun;15(3):277-89. doi: 10.1007/s11248-005-5237-1. Transgenic Res. 2006. PMID: 16779644
-
Mycotoxin risks are lower in biotech corn.Curr Opin Biotechnol. 2022 Dec;78:102792. doi: 10.1016/j.copbio.2022.102792. Epub 2022 Sep 9. Curr Opin Biotechnol. 2022. PMID: 36088737 Review.
-
Assessment of mycotoxin risk on corn in the Philippines under current and future climate change conditions.Rev Environ Health. 2015;30(3):135-42. doi: 10.1515/reveh-2015-0019. Rev Environ Health. 2015. PMID: 26351797
-
U.S. perspective on mycotoxin regulatory issues.Adv Exp Med Biol. 2002;504:277-85. doi: 10.1007/978-1-4615-0629-4_29. Adv Exp Med Biol. 2002. PMID: 11922095 Review.
Cited by
-
The Simultaneous Voltammetric Determination of Aflatoxins В1 and М1 on a Glassy-Carbon Electrode.J Anal Methods Chem. 2018 May 9;2018:6285623. doi: 10.1155/2018/6285623. eCollection 2018. J Anal Methods Chem. 2018. PMID: 29862123 Free PMC article.
-
Aflatoxin regulations in a network of global maize trade.PLoS One. 2012;7(9):e45151. doi: 10.1371/journal.pone.0045151. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049773 Free PMC article.
-
Real and perceived risks for mycotoxin contamination in foods and feeds: challenges for food safety control.Toxins (Basel). 2010 Apr;2(4):572-92. doi: 10.3390/toxins2040572. Epub 2010 Apr 1. Toxins (Basel). 2010. PMID: 22069600 Free PMC article. Review.
-
Exposure to Subclinical Doses of Fumonisins, Deoxynivalenol, and Zearalenone Affects Immune Response, Amino Acid Digestibility, and Intestinal Morphology in Broiler Chickens.Toxins (Basel). 2025 Jan 1;17(1):16. doi: 10.3390/toxins17010016. Toxins (Basel). 2025. PMID: 39852969 Free PMC article.
-
Mycotoxin reduction in Bt corn: potential economic, health, and regulatory impacts.Transgenic Res. 2006 Jun;15(3):277-89. doi: 10.1007/s11248-005-5237-1. Transgenic Res. 2006. PMID: 16779644
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical